Sattva S. Neelapu1 article listing Sattva S. Neelapu in Nature Communications, indexed by Paperzzz from Crossref and OSF.Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial Nature Communications